🇺🇸 FDA
Pipeline program

Placebo, Atoris, 40 mg, tabletki powlekane

2019/ABM/01/00074

Phase 3 small_molecule active

Quick answer

Placebo, Atoris, 40 mg, tabletki powlekane for Chronic obstructive pulmonary disease (COPD) is a Phase 3 program (small_molecule) at Bial Portela & Companhia S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Bial Portela & Companhia S.A.
Indication
Chronic obstructive pulmonary disease (COPD)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials